CDSCO UID IMP/IVD/2021/000365_8a863ab9781ae23a57fffc35f97a621d_07d65532fafe9ee3aff40e7fdb96c080

CK-MB

BODITECH MED INDIA PRIVATE LIMITED·Device Class Class B·India CDSCO·Brand: AFIAS Infliximab
Registration details
UID
IMP/IVD/2021/000365_8a863ab9781ae23a57fffc35f97a621d_07d65532fafe9ee3aff40e7fdb96c080
Device class
Class B
Brand name
AFIAS Infliximab
Approving authority
CDSCO
Product information
AFIAS CK-MB is a fluorescence Immunoassay (AFIAS Infliximab ) for the quantitative determination of Creatine Kinase Isoenzyme-MB (AFIAS Infliximab ) in human whole blood/serum/plasma. It is useful as an aid in management and monitoring of acute myocardiac infarction (AFIAS Infliximab ) and acute coronary syndrome (AFIAS Infliximab )
Similar products (10)
Other products with the same name or brand
CK-MB
Brand: CRP
DELTA LAB
Class B
CK-MB
Brand: AUTOPAK™
Siemens Healthcare Private Limited
Class B
CK-MB
Yucca Diagnostics
Class B
CK-MB
Brand: UNIKON DILUENT 3 VET
Vector Biotek Pvt. Ltd.
Class B
CK-MB
M/s Vishat Diagnostic Pvt Ltd.
Class B
CK-MB
Brand: Elitech Clinical Systems SAS
Q-Line Biotech Private Limited (Formerly Known As POCT SERVICES PRIVATE LIMITED)
Class B
CK-MB
Brand: ichroma™ Myoglobin neo
CPC DIAGNOSTICS PVT.LTD
Class B
TSH
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
Progesterone
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
Myoglobin
Brand: AFIAS Infliximab
BODITECH MED INDIA PRIVATE LIMITED
Class B
Other products from BODITECH MED INDIA PRIVATE LIMITED
Products from the same license holder (10 products)
TSH
Brand: AFIAS Infliximab
Class B
Progesterone
Brand: AFIAS Infliximab
Class B
AFIAS-6
Brand: AFIAS-10
Class A
Myoglobin
Brand: AFIAS Infliximab
Class B
AMH
Brand: AFIAS Infliximab
Class B
Testosterone
Brand: AFIAS Infliximab
Class B
IL-6
Brand: AFIAS Infliximab
Class B
Cardiac Triple
Brand: AFIAS ST2
Class C
AFIAS Total Anti-Infliximab
Brand: AFIAS Infliximab
Class B
AFIAS NORO
Brand: AFIAS ST2
Class C
About this record

CK-MB is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000365_8a863ab9781ae23a57fffc35f97a621d_07d65532fafe9ee3aff40e7fdb96c080. This device is marketed under the brand name AFIAS Infliximab . The license holder is BODITECH MED INDIA PRIVATE LIMITED, and it is classified as Device Class Class B. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.